Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Pfizer claims novel NK2 antagonists for use in urinary incontinence and pain

July 18, 2003

Novel NK1 antagonists for urinary incontinence and other uses in Kyorin pipeline

July 17, 2003

Erectile responses to DA-8159 in rabbit models

July 14, 2003

JNJ-10258859: a novel PDE5 inhibitor with potential in erectile dysfunction

July 14, 2003

Series of potassium channel modulators and their use reported by Wyeth

July 14, 2003

Use of dopamine D3 agonists in sexual dysfunction

July 11, 2003

Human arginase II: a possible target for the treatment of sexual arousal disorders

July 10, 2003

Muscarinic M2/M3 receptor antagonists for urinary incontinence and other uses

July 4, 2003

FDA accepts the NDA for trospium

July 4, 2003

Lilly Icos submits complete response to FDA for Cialis

July 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...